Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Roundhill GLP-1 & Weight Loss ETF
(NQ:
OZEM
)
35.28
-0.24 (-0.68%)
Streaming Delayed Price
Updated: 1:56 PM EST, Dec 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
18,183
Open
35.34
Bid (Size)
35.13 (100)
Ask (Size)
35.28 (300)
Prev. Close
35.52
Today's Range
35.08 - 35.34
52wk Range
20.01 - 35.69
Shares Outstanding
N/A
Dividend Yield
0.15%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain
↗
October 30, 2025
As Eli Lilly, Novo Nordisk, and Pfizer battle for dominance in the obesity-drug market, these ETFs are offering exposure to the GLP-1 gold rush.
Via
Benzinga
Topics
ETFs
Are You Making These 3 ETF Mistakes That Cost You 50% in Gains?
↗
October 13, 2025
Exchange-traded funds are great long-term investments, but you have to think about them in the right way.
Via
The Motley Fool
Topics
ETFs
Performance
YTD
+44.4%
+44.4%
1 Month
+5.8%
+5.8%
3 Month
+31.9%
+31.9%
6 Month
+39.9%
+39.9%
1 Year
+45.5%
+45.5%
More News
Read More
Why Wegovy Maker Novo Nordisk’s Stock Is Sliding 3% Premarket Today
↗
September 29, 2025
Via
Stocktwits
Eli Lilly's Blockbuster Obesity Drugs Miss Sales Estimates Again, But Investors Cheer Q4 Earnings Beat
↗
February 06, 2025
Via
Stocktwits
Eli Lilly Gets Wall Street Backing After Tuesday’s Turmoil, Stock Rises Premarket As Retail Stays Bullish
↗
January 15, 2025
Via
Stocktwits
Topics
Earnings
Eli Lilly Stock Faces Worst Day In Nearly 4 Years On Q4 Weight-Loss Drug Sales Miss, But Retail Bullish On 2025 Projections
↗
January 14, 2025
Via
Stocktwits
Topics
Earnings
Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares
↗
December 13, 2024
Via
Benzinga
Topics
ETFs
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
↗
July 18, 2024
Via
Benzinga
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential
↗
June 07, 2024
Via
Benzinga
Topics
ETFs
New Weight Loss ETF Is Essentially A Play On Eli Lilly, Novo Nordisk
↗
May 30, 2024
Via
Benzinga
Topics
ETFs
Tesla (TSLA) Stock Drops as Glass Lewis Urges Against Elon Musk’s Pay Package
↗
May 28, 2024
Via
InvestorPlace
Campbell Soup Layoffs 2024: What to Know About New Campbell Job Cuts
↗
May 28, 2024
Via
InvestorPlace
Topics
Workforce
OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF
↗
May 28, 2024
Via
InvestorPlace
Topics
ETFs
South Park Took On Crypto, AI Previously: Animated Comedy Targets Weight-Loss Drug Ozempic Next
↗
May 23, 2024
Via
Benzinga
Topics
Artificial Intelligence
EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic
↗
May 21, 2024
Via
Benzinga
Topics
ETFs
Frequently Asked Questions
Is Roundhill GLP-1 & Weight Loss ETF publicly traded?
Yes, Roundhill GLP-1 & Weight Loss ETF is publicly traded.
What exchange does Roundhill GLP-1 & Weight Loss ETF trade on?
Roundhill GLP-1 & Weight Loss ETF trades on the Nasdaq Stock Market
What is the ticker symbol for Roundhill GLP-1 & Weight Loss ETF?
The ticker symbol for Roundhill GLP-1 & Weight Loss ETF is OZEM on the Nasdaq Stock Market
What is the current price of Roundhill GLP-1 & Weight Loss ETF?
The current price of Roundhill GLP-1 & Weight Loss ETF is 35.28
When was Roundhill GLP-1 & Weight Loss ETF last traded?
The last trade of Roundhill GLP-1 & Weight Loss ETF was at 12/29/25 01:56 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.